- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/02 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
Patent holdings for IPC class C07D 215/02
Total number of patents in this class: 119
10-year publication summary
|
13
|
4
|
9
|
9
|
8
|
6
|
6
|
6
|
8
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17950 |
4 |
| Vectus Biosystems Limited | 29 |
4 |
| Georgetown University | 628 |
2 |
| Gilead Sciences, Inc. | 2236 |
2 |
| Katholieke Universiteit Leuven | 1298 |
2 |
| Ludwig-Maximilians-Universitat Munchen | 346 |
2 |
| Sanford Burnham Prebys Medical Discovery Institute | 309 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 876 |
2 |
| Sunshine Lake Pharma Co., Ltd. | 629 |
2 |
| Theralase Technologies Inc. | 42 |
2 |
| Vib VZW | 912 |
2 |
| União Brasileira de Educação e Assistência, Mantenedora da Pucrs | 53 |
2 |
| Sironax LTD | 60 |
2 |
| SpringWorks Therapeutics, Inc. | 156 |
2 |
| Shiv Nadar (institution of Eminence Deemed to BE University) | 5 |
2 |
| Novartis AG | 10173 |
1 |
| Bristol-myers Squibb Company | 4757 |
1 |
| F. Hoffmann-La Roche AG | 7808 |
1 |
| Novartis Pharma AG | 275 |
1 |
| Boehringer Ingelheim International GmbH | 4486 |
1 |
| Other owners | 80 |